at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.

Company profile
Ticker
RMD, RSMDF
Exchange
Website
CEO
Michael Farrell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
ResMed Corp. • ResMed (UK) Ltd • ResMed Asia Pacific Ltd • ResMed Beteiligungs GmbH • ResMed Holdings Pty Ltd • ResMed Pty Ltd • ResMed GmbH and Co • ResMed Motor Technologies Inc. • ResMed SAS • ResMed Paris SAS ...
IRS number
980152841
RMD stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
10 Aug 23
8-K
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
3 Aug 23
SD
Conflict minerals disclosure
26 May 23
10-Q
2023 Q3
Quarterly report
27 Apr 23
8-K
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
27 Apr 23
8-K
Departure of Directors or Certain Officers
30 Mar 23
10-Q
2023 Q2
Quarterly report
26 Jan 23
8-K
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
26 Jan 23
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 22
10-Q
2023 Q1
Quarterly report
27 Oct 22
Transcripts
RMD
Earnings call transcript
2023 Q4
3 Aug 23
RMD
Earnings call transcript
2023 Q3
27 Apr 23
RMD
Earnings call transcript
2023 Q2
26 Jan 23
RMD
Earnings call transcript
2023 Q1
28 Oct 22
RMD
Earnings call transcript
2022 Q4
12 Aug 22
RMD
Earnings call transcript
2022 Q3
29 Apr 22
RMD
Earnings call transcript
2022 Q2
28 Jan 22
RMD
Earnings call transcript
2022 Q1
29 Oct 21
RMD
Earnings call transcript
2021 Q4
6 Aug 21
RMD
Earnings call transcript
2021 Q3
30 Apr 21
Latest ownership filings
4
Michael J. Farrell
19 Sep 23
144
Notice of proposed sale of securities
15 Sep 23
4
Michael J Rider
7 Sep 23
144
Notice of proposed sale of securities
1 Sep 23
4
LUCILE BLAISE
29 Aug 23
4
Michael J Rider
18 Aug 23
4
LUCILE BLAISE
18 Aug 23
4
Kaushik Ghoshal
18 Aug 23
4
Brett Sandercock
18 Aug 23
4
Michael J. Farrell
18 Aug 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 23 | Jun 22 | Jun 21 | Jun 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 227.89 mm | 227.89 mm | 227.89 mm | 227.89 mm | 227.89 mm | 227.89 mm |
Cash burn (monthly) | 1.00 k | 3.82 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 2.88 k | 11.01 mm | n/a | n/a | n/a | n/a |
Cash remaining | 227.89 mm | 216.88 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 227888.1 | 56.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2023
63.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 698 |
Opened positions | 93 |
Closed positions | 49 |
Increased positions | 244 |
Reduced positions | 243 |
13F shares | Current |
---|---|
Total value | 20.39 tn |
Total shares | 93.53 mm |
Total puts | 76.30 k |
Total calls | 855.17 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 17.58 mm | $3.84 tn |
BLK Blackrock | 12.24 mm | $2.67 tn |
STT State Street | 6.39 mm | $1.40 tn |
FMR | 6.09 mm | $1.33 tn |
WCM Investment Management | 3.50 mm | $768.72 bn |
Geode Capital Management | 3.33 mm | $725.60 bn |
Capital World Investors | 2.36 mm | $515.03 bn |
IVZ Invesco | 2.10 mm | $459.05 bn |
Citadel Advisors | 1.86 mm | $406.21 bn |
NTRS Northern Trust | 1.62 mm | $353.04 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Sep 23 | Farrell Michael J. | ResMed Common Stock | Sell | Dispose S | No | Yes | 146.346 | 5,675 | 830.51 k | 449,360 |
15 Sep 23 | Farrell Michael J. | ResMed Common Stock | Option exercise | Acquire M | No | Yes | 57.76 | 5,675 | 327.79 k | 455,035 |
15 Sep 23 | Farrell Michael J. | ResMed Common Stock Options ResMed Common Stock | Option exercise | Dispose M | No | Yes | 57.76 | 5,675 | 327.79 k | 14,815 |
1 Sep 23 | Michael J Rider | ResMed Common Stock | Sell | Dispose S | No | Yes | 161.15 | 25 | 4.03 k | 7,408 |
25 Aug 23 | Lucile Blaise | ResMed Common Stock | Payment of exercise | Dispose F | No | No | 165.67 | 379.689 | 62.90 k | 10,355 |
17 Aug 23 | Farrell Michael J. | ResMed Common Stock | Grant | Acquire A | No | No | 0 | 12,430 | 0.00 | 449,360 |
17 Aug 23 | Sandercock Brett | ResMed Common Stock | Grant | Acquire A | No | No | 0 | 4,972 | 0.00 | 95,915 |
News
Stocks That Hit 52-Week Lows On Thursday
21 Sep 23
10 Health Care Stocks Whale Activity In Today's Session
18 Sep 23
B of A Securities Maintains Buy on ResMed, Lowers Price Target to $230
18 Sep 23
Stocks That Hit 52-Week Lows On Friday
15 Sep 23
Mizuho Maintains Buy on ResMed, Lowers Price Target to $180
13 Sep 23
Press releases
ResMed Announces Participation in Upcoming Conferences
5 Sep 23
Thinking about trading options or stock in Microsoft, Plug Power, TMC the metals company, Resmed, or Solaredge Technologies?
9 Aug 23
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
6 Jul 23
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
5 Jul 23